デフォルト表紙
市場調査レポート
商品コード
1487655

アルツハイマー治療薬市場:世界の産業分析、規模、シェア、成長、動向、2024-2034年予測

Alzheimer's Drugs Market (Drug Class: Cholinergic, Memantine, Combined Drugs, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2034

出版日: | 発行: Transparency Market Research | ページ情報: 英文 175 Pages | 納期: 2~10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=152.86円
アルツハイマー治療薬市場:世界の産業分析、規模、シェア、成長、動向、2024-2034年予測
出版日: 2024年04月01日
発行: Transparency Market Research
ページ情報: 英文 175 Pages
納期: 2~10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

アルツハイマー治療薬市場- 調査範囲

TMRの世界のアルツハイマー治療薬市場に関する調査レポートは、2024年から2034年までの予測期間における市場の指標に関する貴重な洞察を得るために、過去だけでなく現在の成長動向と機会についても調査しています。当レポートでは、2024年を基準年、2034年を予測年として、2018年から2034年までの世界のアルツハイマー治療薬市場の収益を提供しています。また、2024年から2034年までの世界のアルツハイマー治療薬市場の複合年間成長率(CAGR %)も掲載しています。

本レポートは広範な調査を経て作成されました。1次調査では、主要オピニオンリーダー、業界リーダー、オピニオンメーカーへのインタビューを実施しました。2次調査では、主要企業の製品資料、年次報告書、プレスリリース、関連文書などを参照し、アルツハイマー治療薬市場を理解しました。

市場スナップショット
2023年の市場規模 40億米ドル
2034年の市場価値 116億米ドル
CAGR 10%

当レポートでは、世界のアルツハイマー治療薬市場の競合情勢について調査しています。世界のアルツハイマー治療薬市場で事業を展開する主要企業が特定され、各企業が様々な属性でプロファイルされています。企業概要、財務状況、最近の動向、SWOTは、本レポートで紹介されている世界のアルツハイマー治療薬市場におけるプレイヤーの属性です。

目次

第1章 序文

第2章 前提条件と調査手法

第3章 エグゼクティブサマリー:市場

第4章 市場概要

  • イントロダクション
  • 市場概要
  • 市場力学
  • 市場分析と予測、2020年~2034年

第5章 主要洞察

  • パイプライン分析
  • 主要技術・ブランド分析
  • 主要M&A
  • COVID-19パンデミックの産業への影響

第6章 世界市場分析と予測:薬剤クラス別

  • イントロダクションと定義
  • 主な調査結果/発展
  • 市場金額予測:薬剤クラス別、2020年~2034年
    • コリン作動性
    • メマンチン
    • 複合薬
    • その他
  • 市場魅力度分析:薬剤クラス別

第7章 世界市場分析・予測:流通チャネル別

  • イントロダクションと定義
  • 主な調査結果/発展
  • 市場金額予測:流通チャネル別、2020年~2034年
    • 病院薬局
    • 小売薬局
    • オンライン販売
  • 市場魅力度分析:用途別

第8章 世界市場分析・予測:地域別

  • 主な調査結果
  • 市場金額予測:地域別、2020年~2034年
    • 北米
    • 欧州
    • アジア太平洋
    • ラテンアメリカ
    • 中東・アフリカ
  • 市場魅力度分析:地域別

第9章 北米市場の分析と予測

第10章 欧州市場の分析と予測

第11章 アジア太平洋市場の分析と予測

第12章 ラテンアメリカ市場の分析と予測

第13章 中東・アフリカ市場の分析と予測

第14章 競合情勢

  • 市場競合マトリックス(企業階層別・企業規模別)
  • 市場シェア分析:企業別(2023年)
  • 企業プロファイル
    • Allergan plc
    • Novartis AG
    • Eisai Co. Ltd.
    • Johnson & Johnson
    • Daiichi Sankyo Company Limited
    • Ono Pharmaceutical Co. Ltd.
    • H Lundbeck A/S
    • Merz Holding GmbH & Co. KG
図表

List of Tables

  • Table 01: Alzheimer's Drugs Market Size (US$ Mn) Forecast, by Drug Class, 2020-2034
  • Table 02: Alzheimer's Drugs Market Size (US$ Mn) Forecast, by Distribution Channel, 2020-2034
  • Table 03: Alzheimer's Drugs Market Size (US$ Mn) Forecast, by Region, 2020-2034
  • Table 04: North America Alzheimer's Drugs Market Size (US$ Mn) Forecast, by Country, 2020-2034
  • Table 05: North America Alzheimer's Drugs Market Size (US$ Mn) Forecast, by Drug Class, 2020-2034
  • Table 06: North America Alzheimer's Drugs Market Size (US$ Mn) Forecast, by Distribution Channel, 2020-2034
  • Table 07: Europe Alzheimer's Drugs Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
  • Table 08: Europe Alzheimer's Drugs Market Size (US$ Mn) Forecast, by Drug Class, 2020-2034
  • Table 09: Europe Alzheimer's Drugs Market Size (US$ Mn) Forecast, by Distribution Channel, 2020-2034
  • Table 10: Asia Pacific Alzheimer's Drugs Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
  • Table 11: Asia Pacific Alzheimer's Drugs Market Size (US$ Mn) Forecast, by Drug Class, 2020-2034
  • Table 12: Asia Pacific Alzheimer's Drugs Market Size (US$ Mn) Forecast, by Distribution Channel, 2020-2034
  • Table 13: Latin America Alzheimer's Drugs Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
  • Table 14: Latin America Alzheimer's Drugs Market Size (US$ Mn) Forecast, by Drug Class, 2020-2034
  • Table 15: Latin America Alzheimer's Drugs Market Size (US$ Mn) Forecast, by Distribution Channel, 2020-2034
  • Table 16: Middle East & Africa Alzheimer's Drugs Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
  • Table 17: Middle East & Africa Alzheimer's Drugs Market Size (US$ Mn) Forecast, by Drug Class, 2020-2034
  • Table 18: Middle East & Africa Alzheimer's Drugs Market Size (US$ Mn) Forecast, by Distribution Channel, 2020-2034

List of Figures

  • Figure 01: Alzheimer's Drugs Market Size (US$ Mn) and Distribution (%), by Region, 2023 and 2034
  • Figure 02: Alzheimer's Drugs Market Revenue (US$ Mn), by Drug Class, 2023
  • Figure 03: Alzheimer's Drugs Market Value Share, by Drug Class, 2023
  • Figure 04: Alzheimer's Drugs Market Revenue (US$ Mn), by Distribution Channel, 2023
  • Figure 05: Alzheimer's Drugs Market Value Share, by Distribution Channel, 2023
  • Figure 06: Alzheimer's Drugs Market Value Share, by Region, 2023
  • Figure 07: Alzheimer's Drugs Market Value (US$ Mn) Forecast, 2020-2034
  • Figure 08: Alzheimer's Drugs Market Value Share Analysis, by Drug Class, 2023 and 2034
  • Figure 09: Alzheimer's Drugs Market Attractiveness Analysis, by Region, 2024-2034
  • Figure 10: Alzheimer's Drugs Market Value Share Analysis, by Distribution Channel, 2023 and 2034
  • Figure 11: Alzheimer's Drugs Market Attractiveness Analysis, by Distribution Channel, 2024-2034
  • Figure 12: Alzheimer's Drugs Market Value Share Analysis, by Region, 2023 and 2034
  • Figure 13: Alzheimer's Drugs Market Attractiveness Analysis, by Region, 2024-2034
  • Figure 14: North America Alzheimer's Drugs Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034
  • Figure 15: North America Alzheimer's Drugs Market Attractiveness Analysis, by Country, 2024-2034
  • Figure 16: North America Alzheimer's Drugs Market Value Share Analysis, by Country, 2023 and 2034
  • Figure 17: North America Alzheimer's Drugs Market Value Share Analysis, by Drug Class, 2023 and 2034
  • Figure 18: North America Alzheimer's Drugs Market Value Share Analysis, by Distribution Channel, 2023 and 2034
  • Figure 19: North America Alzheimer's Drugs Market Attractiveness Analysis, by Region, 2024-2034
  • Figure 20: North America Alzheimer's Drugs Market Attractiveness Analysis, by Distribution Channel, 2024-2034
  • Figure 21: Europe Alzheimer's Drugs Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034
  • Figure 22: Europe Alzheimer's Drugs Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 23: Europe Alzheimer's Drugs Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 24: Europe Alzheimer's Drugs Market Value Share Analysis, by Drug Class, 2023 and 2034
  • Figure 25: Europe Alzheimer's Drugs Market Value Share Analysis, by Distribution Channel, 2023 and 2034
  • Figure 26: Europe Alzheimer's Drugs Market Attractiveness Analysis, by Region, 2024-2034
  • Figure 27: Europe Alzheimer's Drugs Market Attractiveness Analysis, by Distribution Channel, 2024-2034
  • Figure 28: Asia Pacific Alzheimer's Drugs Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034
  • Figure 29: Asia Pacific Alzheimer's Drugs Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 30: Asia Pacific Alzheimer's Drugs Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 31: Asia Pacific Alzheimer's Drugs Market Value Share Analysis, by Drug Class, 2023 and 2034
  • Figure 32: Asia Pacific Alzheimer's Drugs Market Value Share Analysis, by Distribution Channel, 2023 and 2034
  • Figure 33: Asia Pacific Alzheimer's Drugs Market Attractiveness Analysis, by Region, 2024-2034
  • Figure 34: Asia Pacific Alzheimer's Drugs Market Attractiveness Analysis, by Distribution Channel, 2024-2034
  • Figure 35: Latin America Alzheimer's Drugs Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034
  • Figure 36: Latin America Alzheimer's Drugs Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 37: Latin America Alzheimer's Drugs Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 38: Latin America Alzheimer's Drugs Market Value Share Analysis, by Drug Class, 2023 and 2034
  • Figure 39: Latin America Alzheimer's Drugs Market Value Share Analysis, by Distribution Channel, 2023 and 2034
  • Figure 40: Latin America Alzheimer's Drugs Market Attractiveness Analysis, by Region, 2024-2034
  • Figure 41: Latin America Alzheimer's Drugs Market Attractiveness Analysis, by Distribution Channel, 2024-2034
  • Figure 42: Middle East & Africa Alzheimer's Drugs Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034
  • Figure 43: Middle East & Africa Alzheimer's Drugs Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 44: Middle East & Africa Alzheimer's Drugs Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 45: Middle East & Africa Alzheimer's Drugs Market Value Share Analysis, by Drug Class, 2023 and 2034
  • Figure 46: Middle East & Africa Alzheimer's Drugs Market Value Share Analysis, by Distribution Channel, 2023 and 2034
  • Figure 47: Middle East & Africa Alzheimer's Drugs Market Attractiveness Analysis, by Region, 2024-2034
  • Figure 48: Middle East & Africa Alzheimer's Drugs Market Attractiveness Analysis, by Distribution Channel, 2024-2034
目次
Product Code: TMRGL1245

Alzheimer's Drugs Market - Scope of Report

TMR's report on the global Alzheimer's drugs market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2024 to 2034. The report provides revenue of the global Alzheimer's drugs market for the period 2018-2034, considering 2024 as the base year and 2034 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global Alzheimer's drugs market from 2024 to 2034.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the Alzheimer's drugs market.

Market Snapshot
Market Value in 2023US$ 4 Bn
Market Value in 2034US$ 11.6 Bn
CAGR10%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global Alzheimer's drugs market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global Alzheimer's drugs market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global Alzheimer's drugs market.

The report delves into the competitive landscape of the global Alzheimer's drugs market. Key players operating in the global Alzheimer's drugs market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global Alzheimer's drugs market profiled in this report.

Key Questions Answered in Global Alzheimer's drugs Market Report:

  • What is the sales/revenue generated by Alzheimer's drugs across all regions during the forecast period?
  • What are the opportunities in the global Alzheimer's drugs market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2034?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Alzheimer's Drugs Market - Research Objectives and Research Approach

The comprehensive report on the global Alzheimer's drugs market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global Alzheimer's drugs market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2034 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global Alzheimer's drugs market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Alzheimer's Drugs Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Technology, Definition
    • 4.1.2. Industry Evolution/Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Alzheimer's Drugs Market Analysis and Forecast, 2020-2034

5. Key Insights

  • 5.1. Pipeline Analysis
  • 5.2. Key Technology, /Brand Analysis
  • 5.3. Key Mergers & Acquisitions
  • 5.4. COVID-19 Pandemic Impact on Industry

6. Global Alzheimer's Drugs Market Analysis and Forecast, by Drug Class

  • 6.1. Introduction & Definition
  • 6.2. Key Findings/Developments
  • 6.3. Market Value Forecast, by Drug Class, 2020-2034
    • 6.3.1. Cholinergic
    • 6.3.2. Memantine
    • 6.3.3. Combined Drugs
    • 6.3.4. Others
  • 6.4. Market Attractiveness Analysis, by Drug Class

7. Global Alzheimer's Drugs Market Analysis and Forecast, by Distribution Channel

  • 7.1. Introduction & Definition
  • 7.2. Key Findings/Developments
  • 7.3. Market Value Forecast, by Distribution Channel, 2020-2034
    • 7.3.1. Hospital Pharmacies
    • 7.3.2. Retail Pharmacies
    • 7.3.3. Online Sales
  • 7.4. Market Attractiveness Analysis, by Application

8. Global Alzheimer's Drugs Market Analysis and Forecast, by Region

  • 8.1. Key Findings
  • 8.2. Market Value Forecast, by Region, 2020-2034
    • 8.2.1. North America
    • 8.2.2. Europe
    • 8.2.3. Asia Pacific
    • 8.2.4. Latin America
    • 8.2.5. Middle East & Africa
  • 8.3. Market Attractiveness Analysis, by Region

9. North America Alzheimer's Drugs Market Analysis and Forecast

  • 9.1. Introduction
  • 9.2. Key Findings
  • 9.3. Market Value Forecast, by Drug Class, 2020-2034
    • 9.3.1. Cholinergic
    • 9.3.2. Memantine
    • 9.3.3. Combined Drugs
    • 9.3.4. Others
  • 9.4. Market Value Forecast, by Distribution Channel, 2020-2034
    • 9.4.1. Hospital Pharmacies
    • 9.4.2. Retail Pharmacies
    • 9.4.3. Online Sales
  • 9.5. Market Value Forecast, by Country, 2020-2034
    • 9.5.1. U.S.
    • 9.5.2. Canada
  • 9.6. Market Attractiveness Analysis
    • 9.6.1. By Drug Class,
    • 9.6.2. By Distribution Channel
    • 9.6.3. By Country

10. Europe Alzheimer's Drugs Market Analysis and Forecast

  • 10.1. Introduction
  • 10.2. Key Findings
  • 10.3. Market Value Forecast, by Drug Class, 2020-2034
    • 10.3.1. Cholinergic
    • 10.3.2. Memantine
    • 10.3.3. Combined Drugs
    • 10.3.4. Others
  • 10.4. Market Value Forecast, by Distribution Channel, 2020-2034
    • 10.4.1. Hospital Pharmacies
    • 10.4.2. Retail Pharmacies
    • 10.4.3. Online Sales
  • 10.5. Market Value Forecast, by Country/Sub-region, 2020-2034
    • 10.5.1. Germany
    • 10.5.2. U.K.
    • 10.5.3. France
    • 10.5.4. Italy
    • 10.5.5. Spain
    • 10.5.6. Rest of Europe
  • 10.6. Market Attractiveness Analysis
    • 10.6.1. By Drug Class
    • 10.6.2. By Distribution Channel
    • 10.6.3. By Country/Sub-region

11. Asia Pacific Alzheimer's Drugs Market Analysis and Forecast

  • 11.1. Introduction
  • 11.2. Key Findings
  • 11.3. Market Value Forecast, by Drug Class, 2020-2034
    • 11.3.1. Cholinergic
    • 11.3.2. Memantine
    • 11.3.3. Combined Drugs
    • 11.3.4. Others
  • 11.4. Market Value Forecast, by Distribution Channel, 2020-2034
    • 11.4.1. Hospital Pharmacies
    • 11.4.2. Retail Pharmacies
    • 11.4.3. Online Sales
  • 11.5. Market Value Forecast, by Country/Sub-region, 2020-2034
    • 11.5.1. China
    • 11.5.2. Japan
    • 11.5.3. India
    • 11.5.4. Australia & New Zealand
    • 11.5.5. Rest of Asia Pacific
  • 11.6. Market Attractiveness Analysis
    • 11.6.1. By Drug Class,
    • 11.6.2. By Distribution Channel
    • 11.6.3. By Country/Sub-region

12. Latin America Alzheimer's Drugs Market Analysis and Forecast

  • 12.1. Introduction
  • 12.2. Key Findings
  • 12.3. Market Value Forecast, by Drug Class, 2020-2034
    • 12.3.1. Cholinergic
    • 12.3.2. Memantine
    • 12.3.3. Combined Drugs
    • 12.3.4. Others
  • 12.4. Market Value Forecast, by Distribution Channel, 2020-2034
    • 12.4.1. Hospital Pharmacies
    • 12.4.2. Retail Pharmacies
    • 12.4.3. Online Sales
  • 12.5. Market Value Forecast, by Country/Sub-region, 2020-2034
    • 12.5.1. Brazil
    • 12.5.2. Mexico
    • 12.5.3. Rest of Latin America
  • 12.6. Market Attractiveness Analysis
    • 12.6.1. By Drug Class,
    • 12.6.2. By Distribution Channel
    • 12.6.3. By Country/Sub-region

13. Middle East & Africa Alzheimer's Drugs Market Analysis and Forecast

  • 13.1. Introduction
  • 13.2. Key Findings
  • 13.3. Market Value Forecast, by Drug Class, 2020-2034
    • 13.3.1. Cholinergic
    • 13.3.2. Memantine
    • 13.3.3. Combined Drugs
    • 13.3.4. Others
  • 13.4. Market Value Forecast, by Distribution Channel, 2020-2034
    • 13.4.1. Hospital Pharmacies
    • 13.4.2. Retail Pharmacies
    • 13.4.3. Online Sales
  • 13.5. Market Value Forecast, by Country/Sub-region, 2020-2034
    • 13.5.1. GCC Countries
    • 13.5.2. South Africa
    • 13.5.3. Rest of Middle East & Africa
  • 13.6. Market Attractiveness Analysis
    • 13.6.1. By Drug Class,
    • 13.6.2. By Distribution Channel
    • 13.6.3. By Country/Sub-region

14. Competition Landscape

  • 14.1. Market Player - Competitive Matrix (by Tier and Size of Companies)
  • 14.2. Market Share Analysis, by Company (2023)
  • 14.3. Company Profiles
    • 14.3.1. Allergan plc
      • 14.3.1.1. Company Overview
      • 14.3.1.2. Technology, Portfolio
      • 14.3.1.3. SWOT Analysis
      • 14.3.1.4. Financial Overview
      • 14.3.1.5. Strategic Overview
    • 14.3.2. Novartis AG
      • 14.3.2.1. Company Overview
      • 14.3.2.2. Technology, Portfolio
      • 14.3.2.3. SWOT Analysis
      • 14.3.2.4. Financial Overview
      • 14.3.2.5. Strategic Overview
    • 14.3.3. Eisai Co. Ltd.
      • 14.3.3.1. Company Overview
      • 14.3.3.2. Technology, Portfolio
      • 14.3.3.3. SWOT Analysis
      • 14.3.3.4. Financial Overview
      • 14.3.3.5. Strategic Overview
    • 14.3.4. Johnson & Johnson
      • 14.3.4.1. Company Overview
      • 14.3.4.2. Technology, Portfolio
      • 14.3.4.3. SWOT Analysis
      • 14.3.4.4. Financial Overview
      • 14.3.4.5. Strategic Overview
    • 14.3.5. Daiichi Sankyo Company Limited
      • 14.3.5.1. Company Overview
      • 14.3.5.2. Technology, Portfolio
      • 14.3.5.3. SWOT Analysis
      • 14.3.5.4. Financial Overview
      • 14.3.5.5. Strategic Overview
    • 14.3.6. Ono Pharmaceutical Co. Ltd.
      • 14.3.6.1. Company Overview
      • 14.3.6.2. Technology, Portfolio
      • 14.3.6.3. SWOT Analysis
      • 14.3.6.4. Financial Overview
      • 14.3.6.5. Strategic Overview
    • 14.3.7. H Lundbeck A/S
      • 14.3.7.1. Company Overview
      • 14.3.7.2. Technology, Portfolio
      • 14.3.7.3. SWOT Analysis
      • 14.3.7.4. Financial Overview
      • 14.3.7.5. Strategic Overview
    • 14.3.8. Merz Holding GmbH & Co. KG
      • 14.3.8.1. Company Overview
      • 14.3.8.2. Technology, Portfolio
      • 14.3.8.3. SWOT Analysis
      • 14.3.8.4. Financial Overview
      • 14.3.8.5. Strategic Overview